News
Statement on the FDA and HHS enforcement discretion policy for 503a compounding with certain peptides
“Today’s decision leaves Americans in a grey area as to whether peptides are safe or not, even though the FDA’s own scientists recommended against voting in favor of these substances due to concerns with evidence.”
[...]October 26, 2026: PSM files citizen petition asking FDA not to allow compounding of peptides
The peptides in question are untested and poorly defined, and making them easier to compound is a threat to public safety.
[...]October 19, 2026: Two deaths linked to bootlegged retatrutide
Two deaths have been linked to black market versions of retatrutide, as a British woman warns followers that taking an early dose of the drug “nearly killed” her.
[...]PSM files Citizen Petition with FDA to stop unsafe compounding of untested peptides
Partnership for Safe Medicines filed a citizen petition (CP) with the FDA asking them to refrain from taking action to allow for compounding of drug products using seven peptide bulk drug substances (BPC-157, KPV, TB-500, MOTS-c, emideltide, semax, and epitalon). Learn why here.
[...]October 13, 2026: Mounting evidence that popular unapproved peptide causes cancers
Doctors reported that a man who injected the unregulated peptide he purchased at a gym developed a melanoma lesion after only taking the drug for five weeks.
[...]Remembering Alex Boutin: the hidden risks of performance enhancing drugs
Alex took the advice of older gym veterans about how he could bulk up fast, setting off more than a decade of steroid and, eventually, unregulated peptide use.
[...]Update on drug importation, October 2026
Well-meaning advocates continue to propose importing medicine from foreign countries to lower drug prices for Americans. Past efforts didn’t pay off financially and raised public health risks. Here’s the state of this issue today.
[...]October 5, 2026: Two charged in connection with fake Ozempic that spurred FDA public alert
According to court documents, from at least July 2023 to April 2024, the men allegedly obtained the counterfeit products, which included the packaging, pen labels, and needles, from unauthorized sources in China.
[...]September 28, 2026: FDA warns compounding pharmacy for producing “inordinate amounts” of weight loss drugs for identical prescriptions
The Texas-based 503A compounding facility was warned for continuing to manufacture large amounts of weight loss drugs that are “essentially copies” of brand-name products, which is no longer permitted now that shortages have resolved.
[...]September 21, 2026: Pill press bill passes House as owners of LFA Machines arrested
Three senior employees of the pill press company have been arrested as the U.S. House unanimously passes the Stop Pills That Kill Act, which attempts to disrupt the pill press trade.
[...]